Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aromatase Inhibitors”

448 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 448 results

Large-scale testing (Phase 3)Study completedNCT01160211
What this trial is testing

Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 369
Testing effectiveness (Phase 2)Study completedNCT03822468
What this trial is testing

Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 376
Testing effectiveness (Phase 2)Study completedNCT00333086
What this trial is testing

Letrozole in the Treatment of Endometrial Cancer

Who this might be right for
Recurrent and Metastatic Endometrial Cancer
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Looking for participantsNCT07044310
What this trial is testing

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
Mayo Clinic 38
Large-scale testing (Phase 3)Active Not RecruitingNCT03324932
What this trial is testing

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Who this might be right for
Breast Cancer
Kyoto Prefectural University of Medicine 160
Large-scale testing (Phase 3)Study completedNCT02278120
What this trial is testing

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

Who this might be right for
Advanced Metastatic Breast Cancer
Novartis Pharmaceuticals 672
Testing effectiveness (Phase 2)Active Not RecruitingNCT01992952
What this trial is testing

Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast Cancer
Velindre NHS Trust 149
Not applicableLooking for participantsNCT07448558
What this trial is testing

Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms

Who this might be right for
Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor
Mahidol University 206
Not applicableEnded earlyNCT00504699
What this trial is testing

Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients

Who this might be right for
Breast Cancer
New York Medical College 120
Early research (Phase 1)Study completedNCT04080297
What this trial is testing

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Who this might be right for
Vasomotor Symptoms (VMS)
Que Oncology 21
Large-scale testing (Phase 3)Active Not RecruitingNCT05038735
What this trial is testing

Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 234
Testing effectiveness (Phase 2)Active Not RecruitingNCT03707340
What this trial is testing

Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

Who this might be right for
Breast CancerHyposexual Desire Disorder
Memorial Sloan Kettering Cancer Center 43
Large-scale testing (Phase 3)UnknownNCT02769104
What this trial is testing

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

Who this might be right for
Neoadjuvant Therapy
Zhejiang Cancer Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00272740
What this trial is testing

SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
AstraZeneca 93
Testing effectiveness (Phase 2)Study completedNCT00691678
What this trial is testing

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

Who this might be right for
Breast CancerJoint Pain
Dawn L. Hershman 53
Not applicableStudy completedNCT00809484
What this trial is testing

Arimidex Bone Mass Index and Oral Bisphosphonates

Who this might be right for
Breast CancerBone Density
Hellenic Breast Surgeons Society 220
Not applicableUnknownNCT04308343
What this trial is testing

The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

Who this might be right for
Ectopic Pregnancy
Assiut University 120
Testing effectiveness (Phase 2)Study completedNCT00754325
What this trial is testing

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Who this might be right for
Advanced Breast Cancer
Bristol-Myers Squibb 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04524000
What this trial is testing

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 24
Not applicableStudy completedNCT06086340
What this trial is testing

Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

Who this might be right for
Breast Cancer
Pfizer 779
Load More Results